Article

Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes.

Medical Research Council Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom.
Biological psychiatry (Impact Factor: 9.47). 04/2012; 72(4):311-7. DOI: 10.1016/j.biopsych.2011.12.031
Source: PubMed

ABSTRACT Despite high heritability, the genetic variants influencing bipolar disorder (BD) susceptibility remain largely unknown. Low statistical power to detect the small effect-size alleles believed to underlie much of the genetic risk and possible heterogeneity between cohorts are an increasing concern. Integrative biology approaches might offer advantages over genetic analysis alone by combining different genomic datasets at the higher level of biological processes rather than the level of specific genetic variants or genes. We employed this strategy to identify biological processes involved in BD etiopathology.
Three genome-wide association studies and a brain gene-expression study were combined with the Human Protein Reference Database protein-protein interaction network data. We used bioinformatic analysis to search for biological networks with evidence of association on the basis of enrichment among both genetic and differential-expression associations with BD.
We identified association with gene networks involved in transmission of nerve impulse, Wnt, and Notch signaling. Three features stand out among these genes: 1) they localized to the human postsynaptic density, which is crucial for neuronal function; 2) their mouse knockouts present altered behavioral phenotypes; and 3) some are known targets of the pharmacological treatments for BD.
Genetic and gene-expression associations of BD cluster in discrete regions of the protein-protein interaction network. We found replicated evidence for association for networks involving several interlinked signaling pathways. These genes are promising candidates to generate animal models and pharmacological interventions. Our results demonstrate the potential advantage of integrative biology analyses of BD datasets.

1 Follower
 · 
182 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bipolar disorder (BD) is a severe, chronic, and recurrent psychiatric illness. It has been associated with high prevalence of medical comorbidities and cognitive impairment. Its neurobiology is not completely understood, but recent evidence has shown a wide range of immune changes. Cytokines are proteins involved in the regulation and the orchestration of the immune response. We performed a review on the involvement of cytokines in BD. We also discuss the cytokines involvement in the neuroprogression of BD. It has been demonstrated that increased expression of cytokines in the central nervous system in postmortem studies is in line with the elevated circulating levels of proinflammatory cytokines in BD patients. The proinflammatory profile and the immune imbalance in BD might be regarded as potential targets to the development of new therapeutic strategies.
    Neural Plasticity 01/2014; 2014:360481. DOI:10.1155/2014/360481 · 3.60 Impact Factor
  • Source
    04/2015; 2:58-68. DOI:10.1016/j.cobeha.2014.09.003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Subtle mood fluctuations are normal emotional experiences, whereas drastic mood swings can be a manifestation of bipolar disorder. Despite their importance for normal and pathological behavior, the mechanisms underlying endogenous mood instability are largely unknown. During embryogenesis, the transcription factor Otx2 orchestrates the genetic networks directing the specification of dopaminergic and serotonergic neurons. Here, we behaviorally phenotyped mouse mutants overexpressing Otx2 in the hindbrain, resulting in an increased number of dopaminergic neurons and a decreased number of serotonergic neurons in both developing and mature animals. Over the course of one month, control animals exhibited stable locomotor activity in their home cages, whereas mutants showed extended periods of elevated or decreased activity relative to their individual average. Additional behavioral paradigms, testing for manic- and depressive-like behavior, demonstrated that mutants showed an increase in intra-individual fluctuations in locomotor activity, habituation, risk-taking behavioral parameters, social interaction, and hedonic-like behavior. Olanzapine, lithium, and carbamazepine ameliorated the behavioral alterations of the mutants, as did the mixed serotonin receptor agonist quipazine and the specific 5HT2C receptor agonist CP-809101. Testing the relevance of the genetic networks specifying monoaminergic neurons for bipolar disorder in humans, we applied an interval-based enrichment analysis tool for genome-wide association studies. We observed that the genes specifying dopaminergic and serotonergic neurons exhibit a significant level of aggregated association with bipolar disorder but not with schizophrenia or major depressive disorder. The results of our translational study suggest that aberrant development of monoaminergic neurons leads to mood fluctuations and may be associated with bipolar disorder.Neuropsychopharmacology accepted article preview online, 22 September 2014. doi:10.1038/npp.2014.244.
    Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 09/2014; 40(4). DOI:10.1038/npp.2014.244 · 7.83 Impact Factor

Full-text

Download
60 Downloads
Available from
May 15, 2014